Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes
Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes
Enrolling by invitation · NCT07452913 · Registry updated 2026-03-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Enrolling by invitation | Phase 4 | 2026-03-05 | NCT07452913 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bahria University | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Medical Center Karachi | Karachi | Pakistan | 1 |